MSB 10.4% $1.49 mesoblast limited

Ann: Ulcerative Colitis & Crohns Results Presented at ECCO, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 482 Posts.
    lightbulb Created with Sketch. 37
    Small sample size but 100% effective. Correct?

    If that its the case this should be fairly quick as far as Trials go. 2 weeks to show marked improvement with 3 month checks.

    Would be a good indication to fast track this, its pretty hard to argue against such a high success rate.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.